Renstrup Jens 4
4 · SpringWorks Therapeutics, Inc. · Filed Jan 11, 2021
Insider Transaction Report
Form 4
Renstrup Jens
Chief Medical Officer
Transactions
- Award
Common Stock
[F1]2021-01-07+6,075→ 250,499 total - Award
Stock Option (Right to Buy)
[F2]2021-01-07+48,600→ 48,600 totalExercise: $70.68Exp: 2031-01-07→ Common Stock (48,600 underlying)
Footnotes (2)
- [F1]Represents restricted stock awards. The restricted stock awards shall vest as follows: thirty three percent (33%) to vest on January 7, 2022, another thirty three percent (33%) to vest on January 7, 2023 and the remaining thirty four percent (34%) to vest on January 7, 2024, such that the restricted stock awards are fully vested on January 7, 2024.
- [F2]svThis option shall vest in 48 equal monthly installments subject to continued service to the Company by the Reporting Person.
Signature
/s/ Francis I. Perier, Jr as Attorney-in-Fact|2021-01-11